Cyanotech Corp. of Kona made $605,000 on revenues of $3.9 million for the three months ended Dec. 31, 2009.
That compared with a $514,000 profit on revenues of $3.5 million in the same period in the previous fiscal year.
The Big Island biotech company (Nasdaq: CYAN), which develops and sells microalgae products, attributed the gains to the launch of new products during the quarter, including a multivitamin ay day loans.
“Despite economic challenges, our focus on business fundamentals remains robust,” President and CEO Andrew Jacobson said in a prepared statement.
Shares of Cyanotech were at $3.19 on Thursday, down 12 percent for the day.